231 related articles for article (PubMed ID: 30105908)
1. Streptococcus pneumoniae Sialidase SpNanB-Catalyzed One-Pot Multienzyme (OPME) Synthesis of 2,7-Anhydro-Sialic Acids as Selective Sialidase Inhibitors.
Xiao A; Slack TJ; Li Y; Shi D; Yu H; Li W; Liu Y; Chen X
J Org Chem; 2018 Sep; 83(18):10798-10804. PubMed ID: 30105908
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional studies of Streptococcus pneumoniae neuraminidase B: An intramolecular trans-sialidase.
Gut H; King SJ; Walsh MA
FEBS Lett; 2008 Oct; 582(23-24):3348-52. PubMed ID: 18775704
[TBL] [Abstract][Full Text] [Related]
3. Membrane-enclosed multienzyme (MEME) synthesis of 2,7-anhydro-sialic acid derivatives.
Monestier M; Latousakis D; Bell A; Tribolo S; Tailford LE; Colquhoun IJ; Le Gall G; Yu H; Chen X; Rejzek M; Dedola S; Field RA; Juge N
Carbohydr Res; 2017 Nov; 451():110-117. PubMed ID: 28851488
[TBL] [Abstract][Full Text] [Related]
4. The synthesis of a series of deoxygenated 2,3-difluoro-N-acteylneuraminic acid derivatives as potential sialidase inhibitors.
Hader S; Watts AG
Carbohydr Res; 2013 Jun; 374():23-8. PubMed ID: 23618621
[TBL] [Abstract][Full Text] [Related]
5. Three Streptococcus pneumoniae sialidases: three different products.
Xu G; Kiefel MJ; Wilson JC; Andrew PW; Oggioni MR; Taylor GL
J Am Chem Soc; 2011 Feb; 133(6):1718-21. PubMed ID: 21244006
[TBL] [Abstract][Full Text] [Related]
6. Chemoenzymatic synthesis of sialosides containing C7-modified sialic acids and their application in sialidase substrate specificity studies.
Khedri Z; Li Y; Muthana S; Muthana MM; Hsiao CW; Yu H; Chen X
Carbohydr Res; 2014 May; 389():100-11. PubMed ID: 24680514
[TBL] [Abstract][Full Text] [Related]
7. Chemoenzymatic synthesis of neuraminic acid analogs structurally varied at C-5 and C-9 as potential inhibitors of the sialidase from influenza virus.
Murakami M; Ikeda K; Achiwa K
Carbohydr Res; 1996 Jan; 280(1):101-10. PubMed ID: 8581891
[TBL] [Abstract][Full Text] [Related]
8. Towards the synthesis of sialic acid-based Salmonella typhimurium sialidase inhibitors.
Angus DI; von Itzstein M
Carbohydr Res; 1995 Sep; 274():279-83. PubMed ID: 7585710
[No Abstract] [Full Text] [Related]
9. 9-Azido-9-deoxy-2,3-difluorosialic Acid as a Subnanomolar Inhibitor against Bacterial Sialidases.
Li W; Santra A; Yu H; Slack TJ; Muthana MM; Shi D; Liu Y; Chen X
J Org Chem; 2019 Jun; 84(11):6697-6708. PubMed ID: 31083938
[TBL] [Abstract][Full Text] [Related]
10. Sialidase-catalyzed one-pot multienzyme (OPME) synthesis of sialidase transition-state analogue inhibitors.
Xiao A; Li Y; Li X; Santra A; Yu H; Li W; Chen X
ACS Catal; 2018 Jan; 8(1):43-47. PubMed ID: 29713561
[TBL] [Abstract][Full Text] [Related]
11. Sialidase specificity determined by chemoselective modification of complex sialylated glycans.
Parker RB; McCombs JE; Kohler JJ
ACS Chem Biol; 2012 Sep; 7(9):1509-14. PubMed ID: 22704707
[TBL] [Abstract][Full Text] [Related]
12. A novel sialidase which releases 2,7-anhydro-alpha-N-acetylneuraminic acid from sialoglycoconjugates.
Li YT; Nakagawa H; Ross SA; Hansson GC; Li SC
J Biol Chem; 1990 Dec; 265(35):21629-33. PubMed ID: 2254319
[TBL] [Abstract][Full Text] [Related]
13. A new class of mechanism-based inhibitors for Trypanosoma cruzi trans-sialidase and their influence on parasite virulence.
Carvalho ST; Sola-Penna M; Oliveira IA; Pita S; Gonçalves AS; Neves BC; Sousa FR; Freire-de-Lima L; Kurogochi M; Hinou H; Nishimura S; Mendonça-Previato L; Previato JO; Todeschini AR
Glycobiology; 2010 Aug; 20(8):1034-45. PubMed ID: 20466651
[TBL] [Abstract][Full Text] [Related]
14. Sialidases from gut bacteria: a mini-review.
Juge N; Tailford L; Owen CD
Biochem Soc Trans; 2016 Feb; 44(1):166-75. PubMed ID: 26862202
[TBL] [Abstract][Full Text] [Related]
15. Donor substrate binding to trans-sialidase of Trypanosoma cruzi as studied by STD NMR.
Blume A; Neubacher B; Thiem J; Peters T
Carbohydr Res; 2007 Sep; 342(12-13):1904-9. PubMed ID: 17597593
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of selective inhibitors against V. cholerae sialidase and human cytosolic sialidase NEU2.
Khedri Z; Li Y; Cao H; Qu J; Yu H; Muthana MM; Chen X
Org Biomol Chem; 2012 Aug; 10(30):6112-20. PubMed ID: 22641268
[TBL] [Abstract][Full Text] [Related]
17. Comparative studies of catalytic pathways for Streptococcus pneumoniae sialidases NanA, NanB and NanC.
Xiao K; Wang X; Yu H
Sci Rep; 2019 Feb; 9(1):2157. PubMed ID: 30770840
[TBL] [Abstract][Full Text] [Related]
18. Structure of the catalytic domain of Streptococcus pneumoniae sialidase NanA.
Xu G; Li X; Andrew PW; Taylor GL
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Sep; 64(Pt 9):772-5. PubMed ID: 18765901
[TBL] [Abstract][Full Text] [Related]
19. 2β-3,4-Unsaturated sialic acid derivatives: Synthesis optimization, and biological evaluation as Newcastle disease virus hemagglutinin-neuraminidase inhibitors.
La Rocca P; Rota P; Piccoli M; Cirillo F; Ghiroldi A; Franco V; Allevi P; Anastasia L
Bioorg Med Chem; 2020 Jul; 28(14):115563. PubMed ID: 32616179
[TBL] [Abstract][Full Text] [Related]
20. Identifying selective inhibitors against the human cytosolic sialidase NEU2 by substrate specificity studies.
Li Y; Cao H; Yu H; Chen Y; Lau K; Qu J; Thon V; Sugiarto G; Chen X
Mol Biosyst; 2011 Apr; 7(4):1060-72. PubMed ID: 21206954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
